| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years.
|
J Infect Dis
|
2009
|
5.09
|
|
2
|
Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study.
|
Lancet
|
2011
|
4.70
|
|
3
|
Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.
|
J Natl Cancer Inst
|
2010
|
4.20
|
|
4
|
The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
3.93
|
|
5
|
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years.
|
J Infect Dis
|
2009
|
3.55
|
|
6
|
Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial.
|
BMJ
|
2010
|
3.41
|
|
7
|
Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study.
|
Lancet
|
2013
|
3.25
|
|
8
|
Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine.
|
Vaccine
|
2007
|
2.64
|
|
9
|
Chapter 5: Updating the natural history of HPV and anogenital cancer.
|
Vaccine
|
2006
|
2.51
|
|
10
|
Multiparameter calibration of a natural history model of cervical cancer.
|
Am J Epidemiol
|
2007
|
2.49
|
|
11
|
An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results.
|
Vaccine
|
2008
|
2.48
|
|
12
|
A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions.
|
Cancer Prev Res (Phila)
|
2009
|
2.42
|
|
13
|
Human papillomavirus infections with multiple types and risk of cervical neoplasia.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
2.39
|
|
14
|
HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine.
|
Vaccine
|
2008
|
2.09
|
|
15
|
The epidemiology of oral HPV infection among a multinational sample of healthy men.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
1.94
|
|
16
|
Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia.
|
J Natl Cancer Inst
|
2003
|
1.84
|
|
17
|
Age-specific prevalence of and risk factors for anal human papillomavirus (HPV) among men who have sex with women and men who have sex with men: the HPV in men (HIM) study.
|
J Infect Dis
|
2011
|
1.84
|
|
18
|
Viral load as a predictor of the risk of cervical intraepithelial neoplasia.
|
Int J Cancer
|
2003
|
1.78
|
|
19
|
Type-specific duration of human papillomavirus infection: implications for human papillomavirus screening and vaccination.
|
J Infect Dis
|
2008
|
1.72
|
|
20
|
CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression.
|
J Virol
|
2003
|
1.72
|
|
21
|
Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection.
|
Hum Vaccin
|
2009
|
1.66
|
|
22
|
Human papillomavirus infection and reinfection in adult women: the role of sexual activity and natural immunity.
|
Cancer Res
|
2010
|
1.50
|
|
23
|
Consistent condom use reduces the genital human papillomavirus burden among high-risk men: the HPV infection in men study.
|
J Infect Dis
|
2013
|
1.43
|
|
24
|
Six-month incidence, persistence, and factors associated with persistence of anal human papillomavirus in men: the HPV in men study.
|
J Infect Dis
|
2011
|
1.40
|
|
25
|
Human papillomavirus (HPV) 6, 11, 16, and 18 seroprevalence is associated with sexual practice and age: results from the multinational HPV Infection in Men Study (HIM Study).
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
1.37
|
|
26
|
Methylation of the human papillomavirus-18 L1 gene: a biomarker of neoplastic progression?
|
Virology
|
2006
|
1.33
|
|
27
|
Predictors of cervical coinfection with multiple human papillomavirus types.
|
Cancer Epidemiol Biomarkers Prev
|
2003
|
1.31
|
|
28
|
Occurrence of cervical infection with multiple human papillomavirus types is associated with age and cytologic abnormalities.
|
Sex Transm Dis
|
2003
|
1.30
|
|
29
|
The prevalence of genital HPV and factors associated with oncogenic HPV among men having sex with men and men having sex with women and men: the HIM study.
|
Sex Transm Dis
|
2011
|
1.24
|
|
30
|
Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16.
|
J Virol
|
2005
|
1.22
|
|
31
|
Expression of a family of noncoding mitochondrial RNAs distinguishes normal from cancer cells.
|
Proc Natl Acad Sci U S A
|
2009
|
1.15
|
|
32
|
Interleukin-10 production by tumor infiltrating macrophages plays a role in Human Papillomavirus 16 tumor growth.
|
BMC Immunol
|
2010
|
1.10
|
|
33
|
Epidemiologic approaches to evaluating the potential for human papillomavirus type replacement postvaccination.
|
Am J Epidemiol
|
2013
|
1.09
|
|
34
|
Expression of a novel non-coding mitochondrial RNA in human proliferating cells.
|
Nucleic Acids Res
|
2007
|
1.07
|
|
35
|
Human papillomavirus type 33 polymorphisms and high-grade squamous intraepithelial lesions of the uterine cervix.
|
J Infect Dis
|
2006
|
1.07
|
|
36
|
The role of inflammation in HPV carcinogenesis.
|
Carcinogenesis
|
2010
|
1.07
|
|
37
|
Worldwide genomic diversity of the human papillomaviruses-53, 56, and 66, a group of high-risk HPVs unrelated to HPV-16 and HPV-18.
|
Virology
|
2005
|
1.06
|
|
38
|
Incidence and human papillomavirus (HPV) type distribution of genital warts in a multinational cohort of men: the HPV in men study.
|
J Infect Dis
|
2011
|
1.05
|
|
39
|
Human papillomavirus-16 and -18 in penile carcinomas: DNA methylation, chromosomal recombination and genomic variation.
|
Int J Cancer
|
2008
|
1.05
|
|
40
|
Prevalent serum antibody is not a marker of immune protection against acquisition of oncogenic HPV16 in men.
|
Cancer Res
|
2011
|
1.05
|
|
41
|
Prevalence of human papillomavirus in archival samples obtained from patients with cervical pre-malignant and malignant lesions from Northeast Brazil.
|
BMC Res Notes
|
2010
|
1.03
|
|
42
|
Dietary intake and risk of persistent human papillomavirus (HPV) infection: the Ludwig-McGill HPV Natural History Study.
|
J Infect Dis
|
2003
|
1.01
|
|
43
|
Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like-particle vaccine in Latin American women.
|
Int J Cancer
|
2008
|
1.00
|
|
44
|
Broad HPV distribution in the genital region of men from the HPV infection in men (HIM) study.
|
Virology
|
2013
|
0.99
|
|
45
|
Papillomavirus subtypes are natural and old taxa: phylogeny of human papillomavirus types 44 and 55 and 68a and -b.
|
J Virol
|
2005
|
0.99
|
|
46
|
High-throughput profiling of the humoral immune responses against thirteen human papillomavirus types by proteome microarrays.
|
Virology
|
2010
|
0.99
|
|
47
|
Risk factors for incident condyloma in a multinational cohort of men: the HIM study.
|
J Infect Dis
|
2012
|
0.98
|
|
48
|
Expression of mitochondrial non-coding RNAs (ncRNAs) is modulated by high risk human papillomavirus (HPV) oncogenes.
|
J Biol Chem
|
2012
|
0.98
|
|
49
|
Seroprevalence of human papillomavirus (HPV) type 6 and 16 vary by anatomic site of HPV infection in men.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
0.95
|
|
50
|
Male human papillomavirus prevalence and association with condom use in Brazil, Mexico, and the United States.
|
J Infect Dis
|
2012
|
0.94
|
|
51
|
Awareness and knowledge of HPV, cervical cancer, and vaccines in young women after first delivery in São Paulo, Brazil--a cross-sectional study.
|
BMC Womens Health
|
2010
|
0.92
|
|
52
|
HPV-18 confers resistance to TNF-alpha in organotypic cultures of human keratinocytes.
|
Virology
|
2004
|
0.91
|
|
53
|
Interaction between polymorphisms of the human leukocyte antigen and HPV-16 variants on the risk of invasive cervical cancer.
|
BMC Cancer
|
2008
|
0.90
|
|
54
|
Race and prevalence of human papillomavirus infection among men residing in Brazil, Mexico and the United States.
|
Int J Cancer
|
2012
|
0.90
|
|
55
|
Use of the normalized absorbance ratio as an internal standardization approach to minimize measurement error in enzyme-linked immunosorbent assays for diagnosis of human papillomavirus infection.
|
J Clin Microbiol
|
2010
|
0.90
|
|
56
|
Concordance of human papillomavirus types detected on the surface and in the tissue of genital lesions in men.
|
J Med Virol
|
2013
|
0.90
|
|
57
|
Cutaneous human papillomavirus types detected on the surface of male external genital lesions: a case series within the HPV Infection in Men Study.
|
J Clin Virol
|
2013
|
0.88
|
|
58
|
Smoking and human papillomavirus (HPV) infection in the HPV in Men (HIM) study.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
0.88
|
|
59
|
Human papillomavirus type 16 viral load measurement as a predictor of infection clearance.
|
J Gen Virol
|
2013
|
0.86
|
|
60
|
Associations between serum carotenoids and tocopherols and type-specific HPV persistence: the Ludwig-McGill cohort study.
|
Int J Cancer
|
2007
|
0.85
|
|
61
|
HPV type infection in different anogenital sites among HIV-positive Brazilian women.
|
Infect Agent Cancer
|
2008
|
0.85
|
|
62
|
Prognostic significance of lymph node variables and human papillomavirus DNA in invasive vulvar carcinoma.
|
Gynecol Oncol
|
2004
|
0.85
|
|
63
|
Male circumcision and prevalence of genital human papillomavirus infection in men: a multinational study.
|
BMC Infect Dis
|
2013
|
0.85
|
|
64
|
Opportunity for catch-up HPV vaccination in young women after first delivery.
|
J Epidemiol Community Health
|
2009
|
0.84
|
|
65
|
Low prevalence of HPV in Brazilian children with retinoblastoma.
|
J Med Virol
|
2011
|
0.84
|
|
66
|
Advances in prevention of cervical cancer and other human papillomavirus-related diseases.
|
Pediatr Infect Dis J
|
2006
|
0.84
|
|
67
|
Economic evaluation of strategies for managing women with equivocal cytological results in Brazil.
|
Int J Cancer
|
2010
|
0.84
|
|
68
|
Validation of dot blot hybridization and denaturing high performance liquid chromatography as reliable methods for TP53 codon 72 genotyping in molecular epidemiologic studies.
|
BMC Genet
|
2010
|
0.83
|
|
69
|
Modeling the time dependence of the association between human papillomavirus infection and cervical cancer precursor lesions.
|
Am J Epidemiol
|
2003
|
0.83
|
|
70
|
High genital prevalence of cutaneous human papillomavirus DNA on male genital skin: the HPV Infection in Men Study.
|
BMC Infect Dis
|
2014
|
0.82
|
|
71
|
Male circumcision and the incidence and clearance of genital human papillomavirus (HPV) infection in men: the HPV Infection in men (HIM) cohort study.
|
BMC Infect Dis
|
2014
|
0.82
|
|
72
|
Polymorphisms of the human leukocyte antigen DRB1 and DQB1 genes and the natural history of human papillomavirus infection.
|
J Infect Dis
|
2002
|
0.82
|
|
73
|
Dietary consumption of antioxidant nutrients and risk of incident cervical intraepithelial neoplasia.
|
Gynecol Oncol
|
2010
|
0.82
|
|
74
|
Comparative study of the expression of cellular cycle proteins in cervical intraepithelial lesions.
|
Pathol Res Pract
|
2006
|
0.81
|
|
75
|
Temporal variation and identification of factors associated with endogenous retinoic acid isomers in serum from Brazilian women.
|
Cancer Epidemiol Biomarkers Prev
|
2004
|
0.81
|
|
76
|
Racial differences in the incidence and clearance of human papilloma virus (HPV): the HPV in men (HIM) study.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
0.81
|
|
77
|
Associations of dietary dark-green and deep-yellow vegetables and fruits with cervical intraepithelial neoplasia: modification by smoking.
|
Br J Nutr
|
2010
|
0.81
|
|
78
|
P16(INK4a) expression as a potential prognostic marker in cervical pre-neoplastic and neoplastic lesions.
|
Pathol Res Pract
|
2005
|
0.80
|
|
79
|
Viral load of episomal and integrated forms of human papillomavirus type 33 in high-grade squamous intraepithelial lesions of the uterine cervix.
|
Int J Cancer
|
2007
|
0.80
|
|
80
|
A comparative analysis of clinical and molecular factors with the stage of cervical cancer in a Brazilian cohort.
|
PLoS One
|
2013
|
0.79
|
|
81
|
Lactate transporters and vascular factors in HPV-induced squamous cell carcinoma of the uterine cervix.
|
BMC Cancer
|
2014
|
0.79
|
|
82
|
Accuracy of p53 codon 72 polymorphism status determined by multiple laboratory methods: a latent class model analysis.
|
PLoS One
|
2013
|
0.78
|
|
83
|
A prospective analysis of smoking and human papillomavirus infection among men in the HPV in Men Study.
|
Int J Cancer
|
2013
|
0.78
|
|
84
|
Biomarkers of oxidant load and type-specific clearance of prevalent oncogenic human papillomavirus infection: markers of immune response?
|
Int J Cancer
|
2011
|
0.78
|
|
85
|
Men who purchase sex, who are they? An interurban comparison.
|
J Urban Health
|
2013
|
0.77
|
|
86
|
[Human Papilloma virus in Quechua women from Jujuy with high frequency of cervical cancer: viral types and HPV-16 variants].
|
Medicina (B Aires)
|
2002
|
0.77
|
|
87
|
Polymorphisms in genes involved in folate metabolism modify the association of dietary and circulating folate and vitamin B-6 with cervical neoplasia.
|
J Nutr
|
2013
|
0.77
|
|
88
|
No association between endogenous retinoic acid and human papillomavirus clearance or incident cervical lesions in Brazilian women.
|
Cancer Prev Res (Phila)
|
2010
|
0.77
|
|
89
|
Polymorphism in the promoter region of the Toll-like receptor 9 gene and cervical human papillomavirus infection.
|
J Gen Virol
|
2013
|
0.77
|
|
90
|
Cervical human papillomavirus detection is not affected by menstrual phase.
|
Sex Transm Infect
|
2012
|
0.76
|
|
91
|
Determinants of baseline seroreactivity to human papillomavirus type 16 in the Ludwig-McGill cohort study.
|
BMC Infect Dis
|
2014
|
0.75
|
|
92
|
Circulating biomarkers of iron storage and clearance of incident human papillomavirus infection.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
0.75
|
|
93
|
Lack of agreement between cervicography and cytology and the effect of human papillomavirus infection and viral load.
|
J Low Genit Tract Dis
|
2006
|
0.75
|